As part of the transaction, BC Partners’ advised funds will reinvest in Aenova alongside Kühne Holding AG and continue to support the company as a minority shareholder.

Aenova Group, headquartered in Starnberg near Munich, Germany, is a leading global contract manufacturer and development service provider for the pharmaceutical and healthcare industry. With approximately 4,000 employees in 14 manufacturing sites worldwide, the company is a one-stop service provider for the development, manufacturing, and packaging of drug products for pharma companies around the globe.